What is Ypsomed (YPSN)?
Ypsomed Holding AG is a Swiss medical technology company specializing in the development and production of injection and infusion systems for self-medication. The company provides solutions primarily for diabetes management, including insulin pumps, pen injectors, and related accessories. Ypsomed's products are designed to enhance the ease and accuracy of drug delivery for patients managing chronic conditions. The company operates globally, supplying medical devices to healthcare providers, pharmaceutical companies, and patients. Ypsomed emphasizes innovation, quality, and regulatory compliance in its manufacturing processes. It also invests in research and development to advance its product portfolio and address evolving healthcare needs. The company maintains a focus on patient-centric design and collaborates with partners to integrate digital health technologies into its offerings.
Ypsomed Stock Price Today: Live Overview
The price today is shaped by current market activity, with Ypsomed Holding AG priced at ₣281.3. It has seen a trading range between ₣277.7 and ₣284.2, with a daily percentage change of 0%.
FAQ: Ypsomed (YPSN)
What is the current price of YPSN stock?
The last recorded price is ₣281.3.
Does YPSN pay dividends?
Ypsomed pays dividends to its shareholders.
Does YPSN have a formal corporate presence or regional headquarters in the UAE?
Ypsomed has a registered presence in the UAE through a subsidiary in Dubai.
What is YPSN best known for?
Ypsomed is most famous for its innovative insulin pump systems and diabetes care products.
What assets are typically shown together with YPSN?
Commonly shown alongside YPSN: iShares Bitcoin Trust ETF, Stryker, Getty Images Holdings Inc
Latest shares articles



